Hutt, who was retired partner in residence for Covington & Burling, the Washington firm he rejoined after leaving his post as ...

Australian sunscreen brand Ultra Violette Skincare has beaten global beauty giants to become the first brand to launch a US ...

The megablockbuster helped 40% of children reduce BMI below the obesity threshold at 68 weeks, compared with 0% for placebo, ...

Dietary supplements have emerged as industry’s go-to diversification play as manufacturers pivot from treatment to prevention ...

English-only electronic product information will be permitted in the voluntary phase of Europe’s move from paper to digital ...

What's happening, why it matters and what's next at FDA. This edition covers a one month extension to the deadline which will ...

As the European Medicines Agency prepares to assume a formal role in determining marketing application filing dates, ...

The European Medicines Agency has revamped a voluntary data sharing service for drug developers to submit data related to new ...

The second quarter of 2026 showed a reversal from Q1's seasonal softness, with nine of the world's 10 best-selling drugs ...

In an exclusive interview, Columbus’ Tarn Brown discusses how the EU AI Act puts a new onus on pharma and medtech companies ...

The FDA reiterated that it will not accept foreign clinical trial data generated at site where inspections were denied and ...

Celltrion has received nods for amended Phase III trial plans for its CT-P51 and CT-P44 proposed biosimilars to Keytruda ...